Nicholas Sarlis, Chief Medical Officer of CLEARA Biotech BV:
“I am honored to serve as co-chair of the 2nd Annual Global Cancer Research and Innovation Symposium (GCRIS), taking place October 5–6, 2026, in New York City. The meeting theme is ‘Accelerating Tomorrow’s Cancer Breakthroughs Through Investment and Leading-Edge Science’. A brochure describing the meeting and containing its agenda is attached.
The GCRIS (Global Cancer Research and Innovation Symposium) Program
GCRIS is a unique 1.5-day event connecting the entire drug lifecycle-from investors and Biopharma RandD teams to regulatory agencies and clinical partners. The summit explores the future of pre-commercial therapies, focusing on accelerating market entry through strategic investment, AI integration, and innovative development tools.
Program Highlights
Day 1 Theme: ‘Navigating the Intersection of Science and Capital’
- Focus: Tailored for investors and analysts, featuring expert insights on capital markets, emerging science, and policy shifts impacting private/public enterprise.
- Networking: Includes a social hour and a presentation session showcasing the work of start-up researchers and young investigators supported by Swim Across America (SAA), one of the major event sponsors.
Day 2 Theme: ‘Unlocking Value and Innovation’
- Focus: Bringing together academia, major cancer centers, Biopharma executives, and policy experts to explore the future of oncology. Key discussions include:
Emerging Science: Cutting-edge products in development and successful regulatory pathways.
Technology: Leveraging AI for drug discovery.
Strategic Outlook: A panel of senior oncology leaders discussing ‘where the puck is headed’ to
- Goal: Accelerating the “next generation” products that will transform patient care.
A program description/agenda and a registration.
This event is sponsored by AVBCC (the Association of Value-Based Cancer Care), which is a 16-year-old 501(c)(6) nonprofit dedicated to advancing access, innovation, and collaboration within the cancer care ecosystem.
AVBCC is the founding supporter of Swim Across America (SAA), which funds breakthrough cancer research by supporting young investigators, and has also supported this Symposium.”